The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature.

about

The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature.

Item

http://www.wikidata.org/entity/Q38872926

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The use of patient-reported ou ...... w of the published literature.

@en

type

Item

label

The use of patient-reported ou ...... w of the published literature.

@en

prefLabel

The use of patient-reported ou ...... w of the published literature.

@en

P1476

The use of patient-reported ou ...... w of the published literature.

@en

P2093

Alan L Shields

http://www.w3.org/2001/XMLSchema#string

Denise Globe

http://www.w3.org/2001/XMLSchema#string

Diane M Turner-Bowker

http://www.w3.org/2001/XMLSchema#string

Meaghan Krohe

http://www.w3.org/2001/XMLSchema#string

Nina Galipeau

http://www.w3.org/2001/XMLSchema#string

Yanni Hao

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.

Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer.

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.

Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.

Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials.

Patient-reported outcomes in cancer: a review of recent research and policy initiatives.

The prognostic significance of patient-reported outcomes in cancer clinical trials.

Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.

Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).

P304

1709-1717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/03007995.2016.1205005

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Iyar Mazar

Catherine Foley

P577

2016-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27331272

http://www.w3.org/2001/XMLSchema#string